Bollard Group’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-46,485
| Closed | -$289K | – | 336 |
|
|
2022
Q1 | $289K | Hold |
46,485
| – | – | 0.01% | 201 |
|
|
2021
Q4 | $328K | Hold |
46,485
| – | – | 0.01% | 198 |
|
|
2021
Q3 | $324K | Hold |
46,485
| – | – | 0.01% | 191 |
|
|
2021
Q2 | $387K | Hold |
46,485
| – | – | 0.01% | 176 |
|
|
2021
Q1 | $254K | Hold |
46,485
| – | – | 0.01% | 197 |
|
|
2020
Q4 | $199K | Hold |
46,485
| – | – | 0.01% | 207 |
|
|
2020
Q3 | $140K | Hold |
46,485
| – | – | 0.01% | 223 |
|
|
2020
Q2 | $144K | Buy |
+46,485
| New | +$144K | 0.01% | 215 |
|